The funding directory
8 results · Page 1 of 1 · Reset filters
Supports scientifically based projects that generate knowledge, scientific interpretation or solutions to technological problems. Projects may last up to 36 months. This is a programme profile, not a claim that a specific round is currently open.
Small, short research and doctoral-project R&D support at universities, research hospitals and research institutes. The official page states a maximum duration of 12 months. Supplementary project funding and equipment breakdown or maintenance requests are outside this module.
Project support for doctorate-holding scientists at the start of their research careers. The official programme page states a maximum project duration of 36 months. Career-stage and prior-funding restrictions apply.
Industrial research, technology development and innovation project support. Applications use TÜBİTAK’s PRODİS system. This profile does not establish that a specific application round is open.
Programme profile retained for reference. TÜBİTAK’s 21 July 2026 notice announced a temporary application suspension from 7 August 2026 while the programme was updated. A subsequent reopening date has not been verified here.
The official 9 November extension notice sets the revised dates for the second 2026 SME R&D Start-up call. The programme supports SME R&D and innovation; the call document controls project scope, company eligibility and funding terms.
Order-based SME R&D support under the third 2026 call. TÜBİTAK’s extension notice gives the revised pre-registration and closing dates; applicants must consult the linked 1707 call document for the project and partner conditions.
The 2027 joint call supports development and validation of innovative cell and gene therapies for personalised human medicine. Approaches include somatic-cell therapies, gene therapies, combined cell/gene therapies and specified biological products. Proposals are submitted by multinational consortia…